Sabra Healthcare Reit (DE:SBC)
NASDAQ:SBC
SBC Stock Chart & Stats
€17.84
€0.30(1.90%)
At close: 4:00 PM EST
€17.84
€0.30(1.90%)
Day’s Range― - ―
52-Week Range€14.74 - €17.90
Previous CloseN/A
Volume0.00
Average Volume (3M)10.00
Market Cap
€4.13B
Enterprise Value€7.59B
Total Cash (Recent Filing)€123.45M
Total Debt (Recent Filing)€2.69B
Price to Earnings (P/E)30.5
Beta0.19
Next Earnings
Aug 10, 2026EPS Estimate
0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.64
Shares Outstanding252,190,100
10 Day Avg. Volume4
30 Day Avg. Volume10
Financial Highlights & Ratios
PEG Ratio1.59
Price to Book (P/B)1.62
Price to Sales (P/S)5.90
P/FCF Ratio13.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€19.64Price Target Upside10.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)0.59
Revenue Forecast (FY)€779.00M
Bulls Say, Bears Say
Bulls Say
Cash Flow ResilienceNormalized funds available for distribution met analyst expectations after excluding a small related capital expenditure, indicating resilient distributable cash generation.
Growth Pipeline FundingInvestment activity is accelerating with a sizable, largely pre-funded pipeline, enabling disciplined expansion without immediate capital strain.
Senior Housing Operating PerformanceSame-store net operating income for the senior housing portfolio showed solid growth alongside improving occupancy, supporting steady operating cash flow and demographic-driven demand.
Bears Say
Acquisition Strategy And Organic Growth ConcernsThe SHOP acquisition strategy and platform lack clear differentiation while organic growth in SHOP trails peers, raising concerns about long-term competitive positioning.
Cost Of Capital PressureA higher cost of capital reduces accretion from new investments, constraining return potential relative to lower-cost competitors.
Maturing Loan And Operator Credit RiskAnalysts are seeking more clarity on expectations for a large maturing loan and on the operating partner's financial health, creating refinancing and partnership risk.
Sabra Healthcare REIT News
SBC FAQ
What was Sabra Healthcare Reit’s price range in the past 12 months?
Sabra Healthcare Reit lowest stock price was €14.73 and its highest was €17.90 in the past 12 months.
What is Sabra Healthcare Reit’s market cap?
Sabra Healthcare Reit’s market cap is €4.13B.
When is Sabra Healthcare Reit’s upcoming earnings report date?
Sabra Healthcare Reit’s upcoming earnings report date is Aug 10, 2026 which is in 61 days.
How were Sabra Healthcare Reit’s earnings last quarter?
Sabra Healthcare Reit released its earnings results on Apr 29, 2026. The company reported €0.138 earnings per share for the quarter, missing the consensus estimate of €0.139 by >-€0.001.
Is Sabra Healthcare Reit overvalued?
According to Wall Street analysts Sabra Healthcare Reit’s price is currently Undervalued.
Does Sabra Healthcare Reit pay dividends?
Sabra Healthcare Reit does not currently pay dividends.
What is Sabra Healthcare Reit’s EPS estimate?
Sabra Healthcare Reit’s EPS estimate is 0.14.
How many shares outstanding does Sabra Healthcare Reit have?
Sabra Healthcare Reit has 252,190,100 shares outstanding.
What happened to Sabra Healthcare Reit’s price movement after its last earnings report?
Sabra Healthcare Reit reported an EPS of €0.138 in its last earnings report, missing expectations of €0.139. Following the earnings report the stock price went down -1.292%.
Which hedge fund is a major shareholder of Sabra Healthcare Reit?
Currently, no hedge funds are holding shares in DE:SBC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sabra Healthcare REIT Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€19.64 (10.11% Upside)
€19.64 (10.11% Upside)
Blogger Sentiment
Bullish
DE:SBC Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €262.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.22%
12-Months-Change
Fundamentals
Return on Equity
5.61%
Trailing 12-Months
Asset Growth
6.84%
Trailing 12-Months
Company Description
Sabra Healthcare Reit
As of March 31, 2022, Sabra Health Care REIT, Inc. held a diverse investment portfolio. This largely comprised 416 income-generating real estate properties, which included: 279 skilled nursing and transitional care facilities; 59 senior living communities operating under lease agreements; 50 senior housing properties managed by external operators; 13 behavioral health centers; and 15 specialized hospitals and other healthcare sites. In addition to its real estate holdings, Sabra's portfolio also featured: a single asset earmarked for sale; one sales-type lease arrangement; a total of 16 loan receivables, consisting of two mortgage loans, one construction loan, and thirteen other debt instruments; seven preferred equity stakes; and an interest in one unconsolidated joint venture. Collectively, these 416 investment properties offered a capacity of 41,445 beds and residential units, geographically distributed across both the United States and Canada.
SBC Company Deck
SBC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong and accelerating SHOP deal flow and operating performance (notably robust same-store revenue, occupancy, RevPAR, and NOI growth), record private-pay concentration, healthy FFO/AFFO growth, solid liquidity, and disciplined capital use (forward equity locks). Key negatives are limited and include certain asset transitions (Holiday assets), legal/sale process for Landmark behavioral assets, a highly competitive skilled nursing acquisition market that limits SNF opportunities, modest increases in G&A and the reaffirmation of guidance (conservative stance) with a plan to reassess in Q2. On balance, the positive operating trends, material pipeline, and balance-sheet flexibility outweigh the risks and uncertainties discussed.View all DE:SBC earnings summariesSBC Stock 12 Month Forecast
Average Price Target
€19.64
▲(10.11% Upside)
Technical Analysis
LTC Properties
―
National Health Investors
―
Omega Healthcare
―
―
Diversified Healthcare Trust
―
Options Prices
Currently, No data available
---